• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Allergy Clin Immunol Pract . Age-Related differences in immunological responses to SARS-CoV-2

tetano

Editor, Senior Moderator
J Allergy Clin Immunol Pract


. 2020 Aug 27;S2213-2198(20)30842-4.
doi: 10.1016/j.jaip.2020.08.026. Online ahead of print.
Age-Related differences in immunological responses to SARS-CoV-2


Lydia Su Yin Wong[SUP] 1 [/SUP], Evelyn Xiu Ling Loo[SUP] 2 [/SUP], Alicia Yi Hui Kang[SUP] 3 [/SUP], Hui Xing Lau[SUP] 4 [/SUP], Paul Anantharajah Tambyah[SUP] 5 [/SUP], Elizabeth Huiwen Tham[SUP] 6 [/SUP]



Affiliations

Abstract

There is a striking age-related disparity in the prevalence and severity of SARS-CoV-2 induced COVID-19 infections, which might be explained by age-dependent immunological mechanisms. These include age-related physiological differences in immunological responses, cross-neutralizing antibodies, differences in levels and binding affinity of ACE-2, the SARS-CoV-2 target receptor; antibody dependent enhancement (ADE) in adults manifesting with an over-exuberant systemic inflammation in response to infection; and the increased likelihood of co-morbidities in adults and the elderly. Emerging immunological phenomena such as PMIS-TS (Paediatric Multi-System Inflammatory Disorder Temporally associated with SARS-CoV-2) or MIS-C (Multisystem Inflammatory Syndrome in Children are now being observed, though the underlying mechanisms are still unclear. Understanding the mechanisms through which pediatric patients are protected from severe novel coronaviruses infections will provide critical clues to the pathophysiology of COVID-19 infection and inform future therapeutic and prophylactic interventions. Asymptomatic carriage in children may have major public health implications which impact on social and healthcare policies on screening and isolation practices, school reopening and safe distancing requirements in the community.

Keywords: Age-dependent immunological responses; COVID-19; Pediatric multi-system inflammatory disorder; Prothrombotic phenomena; SARS-CoV-2.
 
Back
Top Bottom